SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040959
Filing Date
2023-08-10
Accepted
2023-08-10 07:30:16
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20230630.htm   iXBRL 10-Q 2253551
2 EX-10.1 glue-ex10_1.htm EX-10.1 89620
3 EX-31.1 glue-ex31_1.htm EX-31.1 22541
4 EX-32.1 glue-ex32_1.htm EX-32.1 13439
  Complete submission text file 0000950170-23-040959.txt   8075642

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glue-20230630_def.xml EX-101.DEF 151646
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glue-20230630_lab.xml EX-101.LAB 414922
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glue-20230630.xsd EX-101.SCH 48439
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glue-20230630_cal.xml EX-101.CAL 42372
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glue-20230630_pre.xml EX-101.PRE 319854
67 EXTRACTED XBRL INSTANCE DOCUMENT glue-20230630_htm.xml XML 1431440
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40522 | Film No.: 231157182
SIC: 2836 Biological Products, (No Diagnostic Substances)